The firm will deliver the speculative development on the 15-acre Cambridge International Technology Park site, which it acquired in September 2021.
The complex designed by Scott Brownrigg will consist of around five major laboratory and office buildings with multistorey car parking and will be built in several phases.
A spokesman for the firm said that procurement for a main contractor would start in the first quarter of 2023.
Construction is believed to be costed at around £200m.
The client team for the major laboratory complex includes project manager and cost consultant Turner and Townsend, MEP engineer Atelier Ten and structural engineer Ramboll.
BioMed’s new development, which is expected to create 2,700 highly-skilled jobs, will be one of the most sustainable in the region.
It will incorporate a number of technologies to reduce energy consumption and improve water usage, resulting in significant carbon emission reductions.
The development is targeting a BREEAM Excellent score and a notable net gain in biodiversity.
The first phase building and car park is expected to be delivered before the end of 2024.